AbbVie Inc. Stock-Based Compensation
AbbVie Inc. (ABBV) reported Stock-Based Compensation of $610.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-03
- AbbVie Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $166.00M, a 7.26% decline year-over-year.
- AbbVie Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $444.00M, a 8.29% increase year-over-year.
- AbbVie Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $157.00M, a 4.27% decline year-over-year.
- AbbVie Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $209.00M, a 15.47% increase year-over-year.
- AbbVie Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $955.00M, a 4.83% increase from fiscal 2024.
- AbbVie Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $911.00M, a 21.95% increase from fiscal 2023.
- AbbVie Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $747.00M, a 11.33% increase from fiscal 2022.
- AbbVie Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $671.00M, a 3.03% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $166.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $610.00M 10-Q · filed 2026-08-03 | $767.00M derived: sum of 3 quarters · filed 2026-08-03 | $976.00M derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | $444.00M 10-Q · filed 2026-05-08 | $601.00M derived: sum of 2 quarters · filed 2026-05-08 | $810.00M derived: sum of 3 quarters · filed 2026-05-08 | $989.00M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | $157.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $366.00M derived: sum of 2 quarters · filed 2026-02-20 | $545.00M derived: sum of 3 quarters · filed 2026-08-03 | $955.00M 10-K · filed 2026-02-20 |
| 2025-09-30 | $209.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $388.00M derived: sum of 2 quarters · filed 2026-08-03 | $798.00M 10-Q · filed 2025-11-04 | $962.00M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | $179.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $589.00M 10-Q · filed 2026-08-03 | $753.00M derived: sum of 3 quarters · filed 2026-08-03 | $934.00M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | $410.00M 10-Q · filed 2026-05-08 | $574.00M derived: sum of 2 quarters · filed 2026-05-08 | $755.00M derived: sum of 3 quarters · filed 2026-05-08 | $973.00M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $164.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $345.00M derived: sum of 2 quarters · filed 2026-02-20 | $563.00M derived: sum of 3 quarters · filed 2026-02-20 | $911.00M 10-K · filed 2026-02-20 |
| 2024-09-30 | $181.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $399.00M derived: sum of 2 quarters · filed 2025-11-04 | $747.00M 10-Q · filed 2025-11-04 | $872.00M derived: sum of 4 quarters · filed 2026-02-20 |
| 2024-06-30 | $218.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | $566.00M 10-Q · filed 2025-08-04 | $691.00M derived: sum of 3 quarters · filed 2026-02-20 | $821.00M derived: sum of 4 quarters · filed 2026-02-20 |
| 2024-03-31 | $348.00M 10-Q · filed 2025-05-09 | $473.00M derived: sum of 2 quarters · filed 2026-02-20 | $603.00M derived: sum of 3 quarters · filed 2026-02-20 | $782.00M derived: sum of 4 quarters · filed 2026-02-20 |
| 2023-12-31 | $125.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $255.00M derived: sum of 2 quarters · filed 2026-02-20 | $434.00M derived: sum of 3 quarters · filed 2026-02-20 | $747.00M 10-K · filed 2026-02-20 |
| 2023-09-30 | $130.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $309.00M derived: sum of 2 quarters · filed 2024-11-04 | $622.00M 10-Q · filed 2024-11-04 | $754.00M derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-06-30 | $179.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $492.00M 10-Q · filed 2024-08-07 | $624.00M derived: sum of 3 quarters · filed 2025-02-14 | $750.00M derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-03-31 | $313.00M 10-Q · filed 2024-05-03 | $445.00M derived: sum of 2 quarters · filed 2025-02-14 | $571.00M derived: sum of 3 quarters · filed 2025-02-14 | $678.00M derived: sum of 4 quarters · filed 2025-02-14 |
| 2022-12-31 | $132.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $258.00M derived: sum of 2 quarters · filed 2025-02-14 | $365.00M derived: sum of 3 quarters · filed 2025-02-14 | $671.00M 10-K · filed 2025-02-14 |
| 2022-09-30 | $126.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $233.00M derived: sum of 2 quarters · filed 2023-11-06 | $539.00M 10-Q · filed 2023-11-06 | $668.00M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-06-30 | $107.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $413.00M 10-Q · filed 2023-08-07 | $542.00M derived: sum of 3 quarters · filed 2024-02-20 | $677.00M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-03-31 | $306.00M 10-Q · filed 2023-05-05 | $435.00M derived: sum of 2 quarters · filed 2024-02-20 | $570.00M derived: sum of 3 quarters · filed 2024-02-20 | $729.00M derived: sum of 4 quarters · filed 2024-02-20 |
| 2021-12-31 | $129.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $264.00M derived: sum of 2 quarters · filed 2024-02-20 | $423.00M derived: sum of 3 quarters · filed 2024-02-20 | $692.00M 10-K · filed 2024-02-20 |
| 2021-09-30 | $135.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $294.00M derived: sum of 2 quarters · filed 2022-11-04 | $563.00M 10-Q · filed 2022-11-04 | $699.00M derived: sum of 4 quarters · filed 2023-02-17 |
| 2021-06-30 | $159.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $428.00M 10-Q · filed 2022-08-04 | $564.00M derived: sum of 3 quarters · filed 2023-02-17 | $726.00M derived: sum of 4 quarters · filed 2023-02-17 |
| 2021-03-31 | $269.00M 10-Q · filed 2022-05-06 | $405.00M derived: sum of 2 quarters · filed 2023-02-17 | $567.00M derived: sum of 3 quarters · filed 2023-02-17 | $803.00M derived: sum of 4 quarters · filed 2023-02-17 |
| 2020-12-31 | $136.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-17 | $298.00M derived: sum of 2 quarters · filed 2023-02-17 | $534.00M derived: sum of 3 quarters · filed 2023-02-17 | $753.00M 10-K · filed 2023-02-17 |
| 2020-09-30 | $162.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $398.00M derived: sum of 2 quarters · filed 2021-11-02 | $617.00M 10-Q · filed 2021-11-02 | $696.00M derived: sum of 4 quarters · filed 2022-02-18 |
| 2020-06-30 | $236.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-02 | $455.00M 10-Q · filed 2021-08-02 | $534.00M derived: sum of 3 quarters · filed 2022-02-18 | $609.00M derived: sum of 4 quarters · filed 2022-02-18 |
| 2020-03-31 | $219.00M 10-Q · filed 2021-05-07 | $298.00M derived: sum of 2 quarters · filed 2022-02-18 | $373.00M derived: sum of 3 quarters · filed 2022-02-18 | $460.00M derived: sum of 4 quarters · filed 2022-02-18 |
| 2019-12-31 | $79.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18 | $154.00M derived: sum of 2 quarters · filed 2022-02-18 | $241.00M derived: sum of 3 quarters · filed 2022-02-18 | $430.00M 10-K · filed 2022-02-18 |
| 2019-09-30 | $75.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $162.00M derived: sum of 2 quarters · filed 2020-11-04 | $351.00M 10-Q · filed 2020-11-04 | $421.00M derived: sum of 4 quarters · filed 2021-02-19 |
| 2019-06-30 | $87.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $276.00M 10-Q · filed 2020-08-04 | $346.00M derived: sum of 3 quarters · filed 2021-02-19 | $421.00M derived: sum of 4 quarters · filed 2021-02-19 |
| 2019-03-31 | $189.00M 10-Q · filed 2020-05-08 | $259.00M derived: sum of 2 quarters · filed 2021-02-19 | $334.00M derived: sum of 3 quarters · filed 2021-02-19 | $419.00M derived: sum of 4 quarters · filed 2021-02-19 |
| 2018-12-31 | $70.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | $145.00M derived: sum of 2 quarters · filed 2021-02-19 | $230.00M derived: sum of 3 quarters · filed 2021-02-19 | $421.00M 10-K · filed 2021-02-19 |
| 2018-09-30 | $75.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $160.00M derived: sum of 2 quarters · filed 2019-11-06 | $351.00M 10-Q · filed 2019-11-06 | $428.00M derived: sum of 4 quarters · filed 2020-02-21 |
| 2018-06-30 | $85.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | $276.00M 10-Q · filed 2019-08-05 | $353.00M derived: sum of 3 quarters · filed 2020-02-21 | $424.00M derived: sum of 4 quarters · filed 2020-02-21 |
| 2018-03-31 | $191.00M 10-Q · filed 2019-05-03 | $268.00M derived: sum of 2 quarters · filed 2020-02-21 | $339.00M derived: sum of 3 quarters · filed 2020-02-21 | $415.00M derived: sum of 4 quarters · filed 2020-02-21 |
| 2017-12-31 | $77.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | $148.00M derived: sum of 2 quarters · filed 2020-02-21 | $224.00M derived: sum of 3 quarters · filed 2020-02-21 | $365.00M 10-K · filed 2020-02-21 |
| 2017-09-30 | $71.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $147.00M derived: sum of 2 quarters · filed 2018-11-07 | $288.00M 10-Q · filed 2018-11-07 | $363.00M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-06-30 | $76.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $217.00M 10-Q · filed 2018-08-07 | $292.00M derived: sum of 3 quarters · filed 2019-02-27 | $361.00M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-03-31 | $141.00M 10-Q · filed 2018-05-04 | $216.00M derived: sum of 2 quarters · filed 2019-02-27 | $285.00M derived: sum of 3 quarters · filed 2019-02-27 | $356.00M derived: sum of 4 quarters · filed 2019-02-27 |
| 2016-12-31 | $75.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $144.00M derived: sum of 2 quarters · filed 2019-02-27 | $215.00M derived: sum of 3 quarters · filed 2019-02-27 | $353.00M 10-K · filed 2019-02-27 |
| 2016-09-30 | $69.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $140.00M derived: sum of 2 quarters · filed 2017-11-07 | $278.00M 10-Q · filed 2017-11-07 | $331.00M derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-06-30 | $71.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $209.00M 10-Q · filed 2017-08-07 | $262.00M derived: sum of 3 quarters · filed 2018-02-16 | $317.00M derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-03-31 | $138.00M 10-Q · filed 2017-05-05 | $191.00M derived: sum of 2 quarters · filed 2018-02-16 | $246.00M derived: sum of 3 quarters · filed 2018-02-16 | $301.00M derived: sum of 4 quarters · filed 2018-02-16 |
| 2015-12-31 | $53.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $108.00M derived: sum of 2 quarters · filed 2018-02-16 | $163.00M derived: sum of 3 quarters · filed 2018-02-16 | $282.00M 10-K · filed 2018-02-16 |
| 2015-09-30 | $55.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $110.00M derived: sum of 2 quarters · filed 2016-11-07 | $229.00M 10-Q · filed 2016-11-07 | $272.00M derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-06-30 | $55.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $174.00M 10-Q · filed 2016-08-05 | $217.00M derived: sum of 3 quarters · filed 2017-02-17 | $261.00M derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-03-31 | $119.00M 10-Q · filed 2016-05-06 | $162.00M derived: sum of 2 quarters · filed 2017-02-17 | $206.00M derived: sum of 3 quarters · filed 2017-02-17 | $254.00M derived: sum of 4 quarters · filed 2017-02-17 |
| 2014-12-31 | $43.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | $87.00M derived: sum of 2 quarters · filed 2017-02-17 | $135.00M derived: sum of 3 quarters · filed 2017-02-17 | $241.00M 10-K · filed 2017-02-17 |
| 2014-09-30 | $44.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $92.00M derived: sum of 2 quarters · filed 2015-11-06 | $198.00M 10-Q · filed 2015-11-06 | $235.00M derived: sum of 4 quarters · filed 2016-02-19 |
| 2014-06-30 | $48.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $154.00M 10-Q · filed 2015-08-07 | $191.00M derived: sum of 3 quarters · filed 2016-02-19 | $233.00M derived: sum of 4 quarters · filed 2016-02-19 |
| 2014-03-31 | $106.00M 10-Q · filed 2015-05-08 | $143.00M derived: sum of 2 quarters · filed 2016-02-19 | $185.00M derived: sum of 3 quarters · filed 2016-02-19 | $231.00M derived: sum of 4 quarters · filed 2016-02-19 |
| 2013-12-31 | $37.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | $79.00M derived: sum of 2 quarters · filed 2016-02-19 | $125.00M derived: sum of 3 quarters · filed 2016-02-19 | $212.00M 10-K · filed 2016-02-19 |
| 2013-09-30 | $42.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $88.00M derived: sum of 2 quarters · filed 2014-11-07 | $175.00M 10-Q · filed 2014-11-07 | $206.00M derived: sum of 4 quarters · filed 2015-02-20 |
| 2013-06-30 | $46.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $133.00M 10-Q · filed 2014-08-07 | $164.00M derived: sum of 3 quarters · filed 2015-02-20 | $194.00M derived: sum of 4 quarters · filed 2015-02-20 |
| 2013-03-31 | $87.00M 10-Q · filed 2014-05-09 | $118.00M derived: sum of 2 quarters · filed 2015-02-20 | $148.00M derived: sum of 3 quarters · filed 2015-02-20 | $183.00M derived: sum of 4 quarters · filed 2015-02-20 |
| 2012-12-31 | $31.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-20 | $61.00M derived: sum of 2 quarters · filed 2015-02-20 | $96.00M derived: sum of 3 quarters · filed 2015-02-20 | $187.00M 10-K · filed 2015-02-20 |
| 2012-09-30 | $30.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $65.00M derived: sum of 2 quarters · filed 2013-11-12 | $156.00M 10-Q · filed 2013-11-12 | |
| 2012-06-30 | $35.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $126.00M 10-Q · filed 2013-08-09 | ||
| 2012-03-31 | $91.00M 10-Q · filed 2013-05-08 | |||
| 2011-12-31 | $163.00M 10-K · filed 2014-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |